273 related articles for article (PubMed ID: 19640172)
21. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus types 16 and 18 mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer.
Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Christopher S; Gravitt P; Abraham P
Int J Gynecol Cancer; 2009 Nov; 19(8):1415-20. PubMed ID: 20009900
[TBL] [Abstract][Full Text] [Related]
23. [Differentiation of an integrated and episomal HPV-16 DNA using real-time PCR in cervical specimens of women diagnosed with intraepithelial lesions and invasive cervical cancer].
Szostek S; Zawilińska B; Klimek M; Wójcik K; Koprynia M; Kosz-Vnenchak M
Ginekol Pol; 2011 Jun; 82(6):441-5. PubMed ID: 21853934
[TBL] [Abstract][Full Text] [Related]
24. Physical and methylation status of human papillomavirus 16 in asymptomatic cervical infections changes with malignant transformation.
Dutta S; Chakraborty C; Dutta AK; Mandal RK; Roychoudhury S; Basu P; Panda CK
J Clin Pathol; 2015 Mar; 68(3):206-11. PubMed ID: 25563334
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus's physical state and cyclin A1 promoter methylation in cervical cancer.
Yanatatsaneejit P; Mutirangura A; Kitkumthorn N
Int J Gynecol Cancer; 2011 Jul; 21(5):902-6. PubMed ID: 21412159
[TBL] [Abstract][Full Text] [Related]
26. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
27. Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma.
Kahla S; Kochbati L; Maalej M; Oueslati R
Asian Pac J Cancer Prev; 2014; 15(6):2869-73. PubMed ID: 24761916
[TBL] [Abstract][Full Text] [Related]
28. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts.
Häfner N; Driesch C; Gajda M; Jansen L; Kirchmayr R; Runnebaum IB; Dürst M
Oncogene; 2008 Mar; 27(11):1610-7. PubMed ID: 17828299
[TBL] [Abstract][Full Text] [Related]
29. [Detection of integration status of human papillomavirus 16 in cervical precancerous lesions].
Chen QY; Bian ML; Chen ZH; Liu J
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):400-4. PubMed ID: 15854531
[TBL] [Abstract][Full Text] [Related]
30. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
31. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
[TBL] [Abstract][Full Text] [Related]
32. Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.
Montealegre JR; Peckham-Gregory EC; Marquez-Do D; Dillon L; Guillaud M; Adler-Storthz K; Follen M; Scheurer ME
Gynecol Oncol; 2018 Feb; 148(2):357-362. PubMed ID: 29276057
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus genotypes associated with cervical neoplasia in India.
Peedicayil A; Abraham P; Sathish N; John S; Shah K; Sridharan G; Gravitt P
Int J Gynecol Cancer; 2006; 16(4):1591-5. PubMed ID: 16884371
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression.
Gimenes F; Souza RP; de Abreu AL; Pereira MW; Consolaro ME; da Silva VR
Arch Gynecol Obstet; 2016 Apr; 293(4):857-63. PubMed ID: 26315473
[TBL] [Abstract][Full Text] [Related]
35. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
Berlin Grace VM
Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
[TBL] [Abstract][Full Text] [Related]
36. Isothermal Method of a Recombinase Polymerase Amplification Assay for the Detection of Most Common High-Risk Human Papillomavirus Type 16 and Type 18 DNA.
Ma B; Fang J; Wang Y; He H; Dai M; Lin W; Su W; Zhang M
Clin Lab; 2017 Jan; 63(1):27-38. PubMed ID: 28164495
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma.
Quint KD; de Koning MN; Geraets DT; Quint WG; Pirog EC
Gynecol Oncol; 2009 Sep; 114(3):390-4. PubMed ID: 19500822
[TBL] [Abstract][Full Text] [Related]
38. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
Cheung JL; Cheung TH; Yu MY; Chan PK
Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.
Guo M; Gong Y; Deavers M; Silva EG; Jan YJ; Cogdell DE; Luthra R; Lin E; Lai HC; Zhang W; Sneige N
J Clin Microbiol; 2008 Jan; 46(1):274-80. PubMed ID: 17977987
[TBL] [Abstract][Full Text] [Related]
40. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
